Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. junior Avg
|
New words:
absorb, accrete, accretion, Alexandra, anthrax, anytime, apportion, ascribe, assimilated, bad, Baltic, Bank, begun, bona, brokerage, buy, buyer, Cohen, concession, contest, counterclaim, Cytiva, deceptive, disaggregated, dispute, drew, endemic, ergonomic, exacerbated, exploring, expressly, Farley, FDIC, fide, Foundation, fractional, hundred, LymeX, MDR, mezzanine, ministerial, mission, nonlease, notably, occupancy, paramount, plague, pool, predominant, preparatory, prize, pro, proportionately, put, question, rata, ratably, reacquired, rehired, resale, residual, resurgence, Road, roll, root, Scandinavian, shortage, Silicon, solidifying, Steven, TCA, therewith, tied, transposed, troubled, tularemia, UDI, Ukraine, unbilled, undermine, underway, underwriter, underwriting, underwritten, undesirable, undistributed, unilaterally, unlawfully, usable, utilizable, Valley, vigorously, White, Windsor, winner
Filing tables
Filing exhibits
- 10-K Annual report
- 4.4 EX-4.4
- 10.51 EX-10.51
- 10.52 EX-10.52
- 10.53 EX-10.53
- 10.54 EX-10.54
- 10.55 EX-10.55
- 10.56 EX-10.56
- 10.64 EX-10.64
- 10.65 EX-10.65
- 10.66 EX-10.66
- 10.67 EX-10.67
- 10.68 EX-10.68
- 10.69 EX-10.69
- 21.1 EX-21.1
- 23.1 EX-23.1
- 31.1 EX-31.1
- 31.2 EX-31.2
- 32.1 EX-32.1
- 32.2 EX-32.2
- Download Excel data file
- View Excel data file
Related press release
Associated TTOO transcripts
TTOO similar filings
Filing view
External links
Exhibit 23.1
Consent of Independent Registered Public Accounting Firm
T2 Biosystems, Inc.
Lexington, Massachusetts
We hereby consent to the incorporation by reference in the Registration Statements on Form S-3 (No. 333-254918, No. 333-206707, No. 333-216833, No. 333-225275, and No. 333-227847) and Form S-8 (No. 333-197946, No. 333-227850, and No. 333-238727) of T2 Biosystems, Inc. of our report dated March 31, 2023, relating to the consolidated financial statements, which appears in this Form 10-K. Our report contains an explanatory paragraph regarding the Company’s ability to continue as a going concern.
/s/ BDO USA, LLP
Boston, Massachusetts
March 31, 2023